Search Results: science-news (2)

Photo: Geoff Pugh/The Telegraph
Ben Whalley, middle, with Dr Gary Stephens and Dr Claire Williams of Reading University at a secret cannabis farm in the south of England in the hope of producing a new treatment for epilepsy

​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.

Worth Repeating

By Ron Marczyk, R.N.

An overwhelming amount of very promising research has been gathered supporting the use of medical cannabis for many illnesses and diseases… and the evidence is now impossible to ignore.

Examples:
“The endogenous cannabinoid system has revealed potential avenues to treat many disease states … Medicinal indications of cannabinoid drugs including compounds that result in enhance endocannabinoid responses (EER) have expanded markedly in recent years.”
“The wide range of indications covers … chemotherapy complications, tumor growth, addiction, pain, multiple sclerosis, glaucoma, inflammation, eating disorders, age-related neurodegenerative disorders, as well as epileptic seizures, traumatic brain injury, cerebral ischemia, and other excitotoxic insults.”
Source: “Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states,” Current Molecular Medicine, September 2006

Photo: NORML Stash Blog
Your tax dollars were used to pay for this dumb-ass billboard just outside of Portland, Oregon.

​The widespread belief that marijuana users will eventually and inevitably move on to harder drugs has yet more evidence against it with the release of a new study from the University of New Hampshire.

Whether teenagers who smoked pot will use other illegal drugs as young adults has a lot more to do with factors such as employment status and stress, according to the new research, reports Science News. In fact, the strongest predictor of whether someone will use hard drugs is their race/ethnicity, not whether they ever used marijuana.
“In light of these findings, we urge U.S. drug control policymakers to consider stress and life-course approaches in their pursuit of solutions to the ‘drug problem,’ ” wrote UNH associate professors of sociology Karen Van Gundy and Cesar Rebellon.